🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral GLP-1 adherence — 12 month update Page 2

Oral GLP-1 adherence — 12 month update

patPC_UT Tue, Dec 17, 2024 at 11:10 AM 46 replies 2,424 viewsPage 2 of 10
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Dec 18, 2024 at 3:41 PM#6
Dr.RenalNash said:
The OASIS programme put 50mg oral in the same territory as 2.4mg injectable — around 15% mean weight loss — but it needed a dose 20 times larger to…

I do not accept that the fasting window is a minor inconvenience. Adherence data on daily orals with timing requirements is consistently worse than weekly injections, and a drug you take imperfectly is a lower dose than the one on the box.

2 22FitDadDave, RunnerRach
Reply Quote Save Share Report
bri_stats
Member
789
3,456
May 2024
Seattle, WA
Dec 19, 2024 at 3:04 AM#7

One concrete data point for the thread. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

1 21mike.trainer_LA
Reply Quote Save Share Report
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Dec 19, 2024 at 2:28 PM#8
Dr.AddMedPHL said:
I do not accept that the fasting window is a minor inconvenience.

There is a second half to this that has not been said yet. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

50 20julia.endo, JessicaM_2024, TomFromTexas and 47 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
kevin_tulsa
Member
489
2,123
Jun 2024
Tulsa, OK
Dec 20, 2024 at 1:52 AM#9

One thing that is still open after zoe_NC’s answer:

How much of the oral variability is the SNAC absorption window and how much is dose, because the two get conflated constantly?

Last edited: Dec 20, 2024 at 3:52 AM
49 19quinn_sf, NurseLeah_Nash, gary_naperville and 46 others
Reply Quote Save Share Report
patPC_UT
Member
212
890
Nov 2024
Park City, UT
Dec 22, 2024 at 8:36 AM#10

Reporting back.

Follow-up: moving the tablet to the moment I wake, before anything else, was the whole fix. The dose never changed.

9 7julia.endo, JessicaM_2024, TomFromTexas and 6 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register